While there is no definitive evidence linking chemicals to increased cancer risk in young people, this is an area of intense ...

As we look ahead in 2025, the pace of discovery in Genetics continues to accelerate, marking the third decade of the 21st century with remarkable ...

UC San Diego study of global lung cancer shows mutations that lead to cancer are common in people who live in cities with bad air pollution. But cancer mutations are quite close to normal among ...

A new drug targets RAS-PI3Kα pathways without harmful side effects. It was developed using high-performance computing and AI.

Langley Perer, a beloved Hollywood manager and producer, died June 25, 2025 following a four-year battle with cancer. She was ...

A pairing of two experimental drugs inhibits tumor growth and blocks drug-induced resistance in ovarian cancer, according to ...

The FDA granted accelerated approval to the tyrosine kinase inhibitor sunvozertinib (Zegfrovy) for advanced non-small cell ...

A pairing of two experimental drugs inhibits tumor growth and blocks drug-induced resistance in ovarian cancer, according to ...

The treatment marks the only targeted oral treatment in patients with non–small cell lung cancer with epidermal growth factor ...

In a primary efficacy population of 85 patients, the confirmed overall response rate was 46%.

Molecular profiling could reduce both overtreatment and undertreatment of patients with high-intermediate risk endometrial ...

Unexpected mutations in blood stem cells may help protect against Alzheimer’s disease. A new study published in the journal ...